Xencor Inc SEC filings XNCR

Xencor Inc has 896 filings in SEC EDGAR's recent list, going back to May 6, 2005. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Xencor Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 26, 2026 Oct 25, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 16, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
8-K Current report
Regulation FD disclosure
May 5, 2026 May 4, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Apr 27, 2026
8-K Current report
Officer or director change
Apr 27, 2026 Apr 23, 2026
8-K Current report
Agreement ended
Mar 9, 2026 Mar 4, 2026
8-K Current report
Regulation FD disclosure
Mar 4, 2026 Mar 4, 2026
S-8 Employee stock plan registration Feb 25, 2026 —
S-3ASR Automatic shelf registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
8-K Current report
Results of operations
Jan 8, 2026 Jan 8, 2026
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Regulation FD disclosure
Oct 24, 2025 Oct 24, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Officer or director change
Jul 31, 2025 Jul 31, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations, Officer or director change
May 7, 2025 May 5, 2025
8-K Current report
Regulation FD disclosure
Apr 30, 2025 Apr 29, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Apr 23, 2025
8-K/A Amended current report
Auditor change
Mar 13, 2025 Feb 27, 2025
8-K Current report
Officer or director change
Mar 13, 2025 Mar 13, 2025
8-K Current report
Auditor change
Mar 5, 2025 Feb 27, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
10-Q/A Amended quarterly report Feb 24, 2025 Sep 30, 2024
10-Q/A Amended quarterly report Feb 24, 2025 Jun 30, 2024
10-Q/A Amended quarterly report Feb 24, 2025 Mar 31, 2024
10-K/A Amended annual report Feb 24, 2025 Dec 31, 2023
8-K Current report
Restatement
Feb 13, 2025 Feb 7, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Officer or director change
Oct 4, 2024 Sep 30, 2024
8-K Current report
Other events
Sep 12, 2024 Sep 12, 2024
8-K Current report
Material agreement, Other events
Sep 12, 2024 Sep 10, 2024
424B5 Prospectus supplement Sep 12, 2024 —
424B5 Prospectus supplement Sep 10, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Sep 9, 2024 Sep 9, 2024
10-Q Quarterly report Aug 5, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 5, 2024 Aug 5, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 13, 2024
8-K Current report
Other events
Jun 13, 2024 Jun 13, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Apr 24, 2024 Apr 24, 2024
8-K Current report
Officer or director change
Apr 9, 2024 Apr 9, 2024
8-K Current report
Regulation FD disclosure
Mar 6, 2024 Mar 6, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
8-K Current report
Material agreement
Nov 15, 2023 Nov 14, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Material agreement
Nov 7, 2023 Nov 3, 2023
8-K Current report
Officer or director change
Oct 26, 2023 Oct 24, 2023
8-K Current report
Officer or director change
Sep 19, 2023 Sep 15, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Officer or director change
Jul 3, 2023 Jun 30, 2023
S-8 Employee stock plan registration Jun 16, 2023 —
S-8 POS Filing Jun 16, 2023 —
S-8 POS Filing Jun 16, 2023 —
S-8 POS Filing Jun 16, 2023 —
S-8 POS Filing Jun 16, 2023 —
8-K Current report
Shareholder vote results
Jun 15, 2023 Jun 14, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
DEFR14A Filing May 1, 2023 —
ARS Annual report to shareholders Apr 26, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 26, 2023 —
DEF 14A Proxy statement Apr 26, 2023 —
8-K Current report
Officer or director change
Apr 26, 2023 Apr 24, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
8-K Current report
Material agreement
Feb 28, 2023 Feb 28, 2023
S-3ASR Automatic shelf registration Feb 27, 2023 —
10-K Annual report Feb 27, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2022 Nov 7, 2022
8-K Current report
Officer or director change
Sep 9, 2022 Sep 9, 2022
S-8 Employee stock plan registration Aug 3, 2022 —
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Shareholder vote results
Jun 28, 2022 Jun 23, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 23, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 23, 2022 Feb 23, 2022
D Filing Nov 19, 2021 —
10-Q Quarterly report Nov 8, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
8-K Current report
Material agreement, Other events
Oct 4, 2021 Oct 1, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 4, 2021 Aug 4, 2021
8-K Current report
Material agreement, New debt
Jul 6, 2021 Jun 30, 2021
8-K Current report
Shareholder vote results
Jun 28, 2021 Jun 24, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
DEFA14A Additional proxy material Apr 28, 2021 —
DEF 14A Proxy statement Apr 28, 2021 Jun 24, 2021
8-K Current report
Officer or director change
Mar 10, 2021 Mar 5, 2021
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 23, 2021 Feb 23, 2021
8-K Current report
Material agreement, Other events
Dec 7, 2020 Dec 4, 2020
8-K Current report
Material agreement
Nov 30, 2020 Nov 24, 2020
10-Q Quarterly report Nov 6, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Regulation FD disclosure
Oct 14, 2020 Oct 14, 2020
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 4, 2020 Aug 4, 2020
8-K Current report
Shareholder vote results
Jun 26, 2020 Jun 25, 2020
10-Q Quarterly report May 8, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 25, 2020
S-8 Employee stock plan registration Feb 25, 2020 —
10-K Annual report Feb 25, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 24, 2020 Feb 24, 2020
8-K Current report
Officer or director change
Dec 20, 2019 Dec 20, 2019
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
SEC STAFF LETTER Filing Sep 27, 2019 —
SEC STAFF LETTER Filing Sep 17, 2019 —
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
CT ORDER Filing Jul 24, 2019 —
CT ORDER Filing Jul 24, 2019 —
CT ORDER Filing Jul 24, 2019 —
8-K Current report
Shareholder vote results
Jun 28, 2019 Jun 26, 2019
8-K Current report
Officer or director change
Jun 27, 2019 Jun 21, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEFA14A Additional proxy material Apr 30, 2019 —
DEF 14A Proxy statement Apr 30, 2019 Jun 26, 2019
8-K Current report
Other events
Mar 8, 2019 Mar 8, 2019
10-K Annual report Feb 26, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 25, 2019 Feb 25, 2019
8-K Current report
Material agreement
Feb 5, 2019 Feb 4, 2019
8-K Current report
Officer or director change
Nov 8, 2018 Nov 7, 2018
10-Q Quarterly report Nov 5, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 5, 2018 Nov 5, 2018
CT ORDER Filing Oct 26, 2018 —
10-Q Quarterly report Aug 7, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 6, 2018 Aug 6, 2018
8-K Current report
Officer or director change
Aug 2, 2018 Jul 27, 2018
8-K Current report
Shareholder vote results
Jun 28, 2018 Jun 26, 2018
10-Q Quarterly report May 7, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 7, 2018 May 7, 2018
DEFA14A Additional proxy material Apr 27, 2018 —
DEF 14A Proxy statement Apr 27, 2018 Jun 26, 2018
8-K Current report
Material agreement
Mar 21, 2018 Mar 20, 2018
424B5 Prospectus supplement Mar 21, 2018 —
424B5 Prospectus supplement Mar 19, 2018 —
S-3ASR Automatic shelf registration Mar 19, 2018 —
10-K Annual report Feb 28, 2018 Dec 31, 2017
8-K Current report
Results of operations
Feb 27, 2018 Feb 27, 2018
8-K Current report
Officer or director change
Dec 19, 2017 Dec 18, 2017
10-Q Quarterly report Nov 8, 2017 Sep 30, 2017
8-K Current report
Results of operations
Nov 7, 2017 Nov 7, 2017
UPLOAD Letter from the SEC Sep 21, 2017 —
CORRESP Letter to the SEC Aug 30, 2017 —
UPLOAD Letter from the SEC Aug 10, 2017 —
10-Q Quarterly report Aug 7, 2017 Jun 30, 2017
8-K Current report
Results of operations
Aug 7, 2017 Aug 7, 2017
CORRESP Letter to the SEC Aug 3, 2017 —
UPLOAD Letter from the SEC Jul 11, 2017 —
8-K Current report
Material agreement
Jul 10, 2017 Jul 5, 2017
8-K Current report
Material agreement, Shareholder vote results
Jun 26, 2017 Jun 21, 2017
CORRESP Letter to the SEC Jun 22, 2017 —
UPLOAD Letter from the SEC Jun 22, 2017 —
8-K Current report
Other events
May 11, 2017 May 9, 2017
10-Q Quarterly report May 10, 2017 Mar 31, 2017
8-K Current report
Results of operations
May 9, 2017 May 9, 2017
DEFA14A Additional proxy material May 1, 2017 —
DEF 14A Proxy statement May 1, 2017 Jun 22, 2017
8-K Current report
Officer or director change
Apr 17, 2017 Apr 11, 2017
8-K Current report
Officer or director change
Mar 6, 2017 Feb 27, 2017
S-8 Employee stock plan registration Mar 1, 2017 —
10-K Annual report Mar 1, 2017 Dec 31, 2016
8-K Current report
Results of operations
Feb 28, 2017 Feb 27, 2017
8-K Current report
Material agreement
Dec 1, 2016 Nov 30, 2016
424B5 Prospectus supplement Dec 1, 2016 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XNCR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Pasadena, CA
SEC filer status
Accelerated filer
SEC CIK
1326732

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.